As chemokine decoy receptors (D6, DARC, CCX-CKR) were expressed in glioma as well as LOX cells, they could be ruled out as mediators for tm-chemokine effects that were absent in the melanoma cells. This evidence concerns the gene ACKR2 and central nervous system cancer.